These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14671567)

  • 1. [Metoprolol in the treatment of essential hypertension].
    Minushkina LO; Sidorenko BA
    Kardiologiia; 2003; 43(11):102-5. PubMed ID: 14671567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and cardiac effects of antihypertensive treatment with ramipril versus metoprolol in autosomal dominant polycystic kidney disease.
    Steinman TI
    Nephrol Dial Transplant; 2008 Feb; 23(2):431-3. PubMed ID: 18065782
    [No Abstract]   [Full Text] [Related]  

  • 3. Metoprolol succinate extended release/hydrochlorothiazide combination tablets.
    Hainer JW; Sugg J
    Vasc Health Risk Manag; 2007; 3(3):279-88. PubMed ID: 17703635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of metoprolol CR/ZOK in the cardiological practice].
    Podzolkov VI; Samoĭlenko VV; Osadchiĭ KK; Strizhakov LA
    Ter Arkh; 2000; 72(9):78-80. PubMed ID: 11076427
    [No Abstract]   [Full Text] [Related]  

  • 5. S-metoprolol: the 2008 clinical review.
    Dasbiswas A; Shinde S; Dasbiswas D
    J Indian Med Assoc; 2008 Apr; 106(4):259-62. PubMed ID: 18828349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metoprolol succinate combination in the treatment of hypertension.
    Papadopoulos DP; Papademetriou V
    Angiology; 2009; 60(5):608-13. PubMed ID: 19033265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI; Spasskaia MB; Nebieridze DV; Metel'skaia VA; Guseva OI
    Klin Med (Mosk); 2003; 81(7):51-5. PubMed ID: 12934313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial.
    Espinola-Klein C; Weisser G; Jagodzinski A; Savvidis S; Warnholtz A; Ostad MA; Gori T; Munzel T
    Hypertension; 2011 Aug; 58(2):148-54. PubMed ID: 21646599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confusing messages from the newest of the beta-blocker/diuretic hypertension trials. The Metoprolol Atherosclerosis Prevention in Hypertensives trial.
    Moser M; Sheps S
    Arch Intern Med; 1989 Oct; 149(10):2174-5. PubMed ID: 2572204
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atenolol or metoprolol as beta-blocker in the treatment of hypertension].
    van den Born BJ; Brewster LM; Koopmans RP; van Montfrans GA
    Ned Tijdschr Geneeskd; 2005 Aug; 149(32):1808-9. PubMed ID: 16121668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of combination therapy with lacidipine and beta-adrenoblockers in patients with hypertension].
    Glezer MG; Abil'dinova AZh
    Kardiologiia; 2002; 42(9):43-8. PubMed ID: 12494073
    [No Abstract]   [Full Text] [Related]  

  • 13. Body weight changes with beta-blocker use: results from GEMINI.
    Messerli FH; Bell DS; Fonseca V; Katholi RE; McGill JB; Phillips RA; Raskin P; Wright JT; Bangalore S; Holdbrook FK; Lukas MA; Anderson KM; Bakris GL;
    Am J Med; 2007 Jul; 120(7):610-5. PubMed ID: 17602935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factorial antihypertensive study of an extended-release metoprolol and hydrochlorothiazide combination.
    Papademetriou V; Hainer JW; Sugg J; Munzer D;
    Am J Hypertens; 2006 Dec; 19(12):1217-25. PubMed ID: 17161766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metoprolol (Lopressor).
    Med Lett Drugs Ther; 1978 Nov; 20(22):97-8. PubMed ID: 30035
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antihypertensive activity and effect on parameters of heart rate variability of beta-blockers carvedilol and metoprolol].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA
    Kardiologiia; 2005; 45(11):17-23. PubMed ID: 16353059
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prospects of use of the combined preparation logimax in patients with essential hypertension].
    Ol'binskaia LI; Khapaev BA; Zheleznykh EA
    Ter Arkh; 2002; 74(1):61-3. PubMed ID: 11878064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of beta-blockers on the cardiac rhythm variability in patients with hypertension].
    Bil'chenko AV
    Lik Sprava; 2002; (1):38-41. PubMed ID: 11944376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect and tolerability of metoprolol during long-term treatment: a multicentre study.
    Rosengard S
    J Int Med Res; 1977; 5(3):199-206. PubMed ID: 19328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complex assessment of efficacy and tolerance of metoprolol CR/ZOK in treating hypertension].
    Podzolkov VI; Strizhakov LA; Pavlov VI; Makolkin VI
    Ter Arkh; 2002; 74(11):74-7. PubMed ID: 12498136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.